Conclusions
bladder cancer
BLADDER CANCER
Conclusively, we did not find ePROs effective for the bladder cancer patients in relation to the chosen endpoints. We observed a high level of clinician engagement in using the ePROs and a positive impact on patients’ emotional functioning. Our study demonstrates the caveats in applying PROs across patient groups as a result of the increased awareness to PROs over the past years. For the bladder cancer patients with limited resources this approach may be unnecessarily time consuming in what sparse time left. The study group continues to evaluate the collected PRO data in order to find subsets of symptoms indicative for one or more of the chosen endpoints. Thus, further analyses will be made with the overall aim of improving the clinical courses of patients with bladder cancer.